A cross-sectional study on the prevalence of HIV drug resistance in patients receiving antiretroviral treatment in Shenqiu county, Henan province
10.3760/cma.j.issn.0254-6450.2013.03.004
- VernacularTitle:河南省沈丘县抗病毒治疗者HIV耐药株流行状况调查
- Author:
Wei-Guo CUI
1
;
Xiu-Juan XUE
;
Jia LIU
;
Guo-Qing SUN
;
Chun-Hua LIU
;
Sui-An TIAN
;
Zhe WANG
;
Han-Ping LI
;
Jing-Yun LI
Author Information
1. 河南省疾病预防控制中心性病艾滋病预防控制所
- Keywords:
HIV;
Antiretroviral therapy;
Drug resistance
- From:
Chinese Journal of Epidemiology
2013;34(3):218-220
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the prevalence of drug resistance in AIDS patients who had been receiving HAART in a long run,in Shenqiu county,Henan province.Methods This crosssectional study included 120 HIV infected patients who began receiving ART (antiretroviral therapy) in 2003.Viral loads and CD4 +T cells counts were measured,and In-house drug resistance test was performed in VL ＞ 1000 copies/ml patients.Results 114 cases out of 120 patients had complete viral load data.Among them,33 cases having viral loads less than 50 copies/ml,and the remaining viral loads showed an average of lg (4.09 ± 1.10) copies/ml.The average of CD4+ T cell counts was (377 ±2 1 8) cells/ml,with 64 (53.3％) cases showing their CD4+ T cell counts higher than 350 cells/ml.In 67 patients,58 of them showed genotypic resistance,and 40 cases showed reverse transcriptase inhibitors (RTIs) resistance.The ratios of nucleoside reverse transcriptase inhibitors (NRTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) resistance were 53.4％ (31/58) and 67.2％ (39/58),respectively.There were no differences of drug resistance ratio in the three treatment programs.The highest drug resistance rates in NRTIs and NNRTIs were zidovudine,lamivudin,nevirapine.However,protease inhibitors (PIs) resistance variants were not found.Conclusion The prevalence of drug-resistant strains seemed to be high in Shenqiu country,Henan province.Long-term follow-up monitoring strategy should be developed to optimize the timely treatment programs.
